ClinicalTrials.Veeva

Menu
H

Hartford Healthcare | Cancer Clinical Research Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nivolumab
CMP-001
Capecitabine
risperidone
VB-111
Labetalol
Dostarlimab
Bevacizumab
capecitabine
5-FU

Parent organization

This site is a part of Hartford Healthcare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 40 total trials

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermed...

Enrolling
Myelofibrosis
Drug: Imetelstat
Drug: Best Available Therapy (BAT)

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure...

Enrolling
Diastolic Heart Failure
Heart Failure With Preserved Ejection Fraction
Device: OPTIMIZERâ„¢ Smart Mini System
Device: Cardiac Contractility Modulation Therapy via OPTIMIZERâ„¢ Smart Mini System

The goal of this clinical trial is to demonstrate that the OPTIMIZER® Integra CCM-D System (the "CCM-D System") can safely and effective convert indu...

Enrolling
CCM Therapy
Arrhythmias, Cardiac
Device: OPTIMIZER® Integra CCM-D System (Treatment Arm)

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of n...

Enrolling
Persistent Atrial Fibrillation
Longstanding Persistent Atrial Fibrillation
Procedure: Surgical Ablation
Device: Cardioblate and Cryoflex hand held devices

Prospective, non-randomized, multi-center clinical investigation of the NEXUSâ„¢ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic...

Enrolling
Intramural Hematoma
Penetrating Aortic Ulcer
Device: NEXUS Aortic Stent Graft System

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Active, not recruiting
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thromb...

Enrolling
Pulmonary Embolism Acute
Device: ATC

The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine...

Enrolling
Solid Tumor
Rectal Adenocarcinoma
Drug: capecitabine or 5-FU
Drug: TSR-042 or Dostarlimab

The purpose of this study is to find out whether treatment with the study drug durvalumab combined with a type of radiation therapy called stereotact...

Active, not recruiting
Non-small Cell Lung Cancer Stage II
PD-L1 Gene Mutation
Radiation: Stereotactic Body Radiation Therapy
Drug: Durvalumab

Trial sponsors

Memorial Sloan Kettering Cancer Center (MSK) logo
I
Regeneron Pharmaceuticals logo
Yale University logo
A
A
Bristol-Myers Squibb (BMS) logo
E
G
Hartford Hospital logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems